생명과학회지 (Journal of Life Science)

  • 제28권6호
  • /
  • Pages.726-732
  • /
  • 2018
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

Bacillus polyfermenticus KJS-2와 참당귀 추출물의 triton WR-1339 유발 고지혈증에 대한 예방효과

The Preventive Effect of Bacillus polyfermenticus KJS-2 and Angelica gigas Nakai Extract on Triton WR-1339-induced Hyperlipidemia

  • Kim, Kang Min (Department of Pharmaceutical Science and Technology, Kyungsung University) ;
  • Kim, Bo Seul (Department of Pharmacy, Kyungsung University) ;
  • Kang, Jae Seon (Department of Pharmacy, Kyungsung University)
  • 투고 : 2018.01.10
  • 심사 : 2018.03.22
  • 발행 : 2018.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

이번 연구의 목표는 Bacillus polyfermenticus KJS-2 (B. polyfermenticus KJS-2) 및 Angelica gigas Nakai extracts(AGNE) 추출물의 고지혈증에 대한 효과를 확인 하기 위한 것이다. AGNE에 활성을 나타내는 성분인 decursin과 decursinol angelate (D/DA)의 순도를 확인하였을 때 약 78%로 나타났다. AGNE (0.1-20 mg/ml)를 이용한 HMG-CoA reductase 저해활성은 농도가 증가함에 따라 높은 활성을 나타내었다. Endospore를 형성한 B. polyfermenticus KJS-2 ($1{\times}10^9CFU/ml$)는 약 0.3 mm의 담즙산이 함유된 배지에서 내성이 관찰되었다. Normal control, positive control (atorvastatin), negative control (triton WR-1339) 및 AGNE, B. polyfermenticus KJS-2, AGNE + B. polyfermenticus KJS-2와 Atorvastatin + AGNE + B. polyfermenticus KJS-2투여군의 7개군으로 나누어 실시한 동물실험에서는 몸무게 및 간의 무게는 거의 차이가 없었으나, 신장의 무게는 triton WR-1339만 처리한 군에서 조금 높게 나타났다. B. polyfermenticus KJS-2 및 AGNE를 투여는 HDL-콜레스테롤은 증가시키고, 총콜레스테롤 및 중성지방 함량은 감소시켰다. 또한, 간조직 내에서의 지방 축적 정도를 확인한 결과 B. polyfermenticus KJS-2 및 AGNE투여군에서는 지방 염색의 감소가 나타나 지방의 축적이 감소하였음을 알 수 있다. 따라서, B. polyfermenticus KJS-2 및 AGNE는 고지혈증에 효과가 있음을 시사한다.

The purpose of this study was to investigate the effects of Bacillus polyfermenticus KJS-2 (B. polyfermenticus KJS-2) and Angelica gigas Nakai extracts (AGNE) on hyperlipidermia. The purity of the major decursin and decursinol angelate (D/DA) in the AGNE were analyzed at 78%. Increased concentrations of AGNE (0.1-20 mg/ml) showed a higher 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibition activity. Endospore-forming B. polyfermenticus KJS-2 ($1{\times}10^9CFU/ml$) exhibited good bile tolerance (0.3 mm) on an agar plate. An animal study was carried out using different groups, including a normal control, positive control (atorvastatin), negative control (triton WR-1339), AGNE group, B. polyfermenticus KJS-2 group, AGNE + B. polyfermenticus KJS-2 group, and Atorvastatin + AGNE + B. polyfermenticus KJS-2 group to determine the effect of hyperlipidemia. There were no significant changes in body weight, kidney weight, or liver weight except for the liver weight of the triton WR-1339-treated group. Groups with AGNE and B. polyfermenticus KJS-2 had increased HDL-cholesterol and decreased total cholesterol and triglycerides. The liver histopathological results also showed that all AGNE and B. polyfermenticus KJS-2-treated groups contained lower fat accumulation in the liver tissues. The findings of this study verified that AGNE and Endospore-forming B. polyfermenticus KJS-2 combination materials have a hyperlipidemic effect.

키워드

참고문헌

  1. Choi, S. W., Bai, D. H., Yu, J. H. and Shin, C. S. 2003. Characteristics of the squalene synthase inhibitors produced by a Streptomyces species isolated from soils. Can. J. Microbiol. 49, 663-668. https://doi.org/10.1139/w03-084
  2. Cho, M. S. 2010. Production optimization of spore and macrolatin A from Bacillus polyfermenticus KJS-2. Master. dissertation, Inje university, Kimhae, Korea.
  3. Choi, S. M., Park, M. H., Jung, T. S., Moon, K. H., Kim, K. M. and Kang, J. S. 2011. Characterization of Bacillus mojavensis KJS-3 for industrial applications. Arch. Pharm. Res. 34, 289-298. https://doi.org/10.1007/s12272-011-0215-z
  4. Dashkevicz, M. P. and Feighner, S. D. 1989. Development of a differential medium for bile salt hydrolase-active Lactobacillus spp. Appl. Environ. Microbiol. 55, 11-16.
  5. Getachew, T. 2016. A review on effects of probiotic supplementation in poultry performance and cholesterol levels of egg and meat. J. World Poult. Res. 6, 31-36.
  6. Ha, T. H. 2013. Effects of ephedra herba ethyl-acetate fraction (EEAF) on hyperlipidmicmice. Ph. D. dissertation, Dong-eui University, Busan, Korea.
  7. Jun, K. D., Kim, H. J., Lee, K. H., Paik, H. D. and Kang, J. S. 2002. Characterization of Bacillus polyfermenticus SCD as a probiotic. Kor. J. Microbiol. Biotechnol. 30, 359-366.
  8. Kang, J. S., Ji, Y. H., Lee, S. H., Kim, B. S., Ha, S. M., Kim, D. H. and Hong, Y. G. 2006. Pharmaceutical composition for treating hyperlipidaemia. Korea patent 10-1658350.
  9. Kang, J. S., Jun, K. D., Kim, W. S., Jo, W. S., Kwon, J. Y. and Moon, K. H. 2004. Antibacterial Activities of B. polyfermenticus SCD against pathogenic bacteria and effects on animals and humans. Yakhak Hoeji 48, 70-74.
  10. Kim, D. H., Kang, K. R., Kim, H. W., Yoon, S. Y., Kim, C. G., Yamaguchi, T., Kyung, S. J. and Kang, J. S. 2010. Structure determination of macrolactin compounds with antibacterial activities isolated from Bacillus polyfermenticus KJS-2. J. Life Sci. 20, 1792-1800. https://doi.org/10.5352/JLS.2010.20.12.1792
  11. Kim, D. H., Kim, H. K., Kim, K. M., Kim, C. K., Jeong, M. H., Ko, C. Y., Moon, K. H. and Kang, J. S. 2011. Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Arch. Pharm. Res. 34, 147-152. https://doi.org/10.1007/s12272-011-0117-0
  12. Kim, G. S., Park, C. G., Jeong, T. S., Cha, S. W., Baek, N. I. and Song, K. S. 2009. ACAT (Acyl-CoA:cholesterol Acyltransferase) inhibitory effect and quantification of pyranocurmarin in different parts of Angelica gigas Nakai. J. Appl. Biol. Chem. 52, 188-194.
  13. Kim, K. M., Jung, J. Y., Hwang, S. W., Kim, M. J. and Kang, J. S. 2009. Isolation and purification of decursin and decursinol angelate in Angelica gigas Nakai. J. Kor. Soc. Food Sci. Nutr. 38, 653-656. https://doi.org/10.3746/jkfn.2009.38.5.653
  14. Kim, K. M., Kim, M. J., Kim, D. H., Park, Y. S. and Kang, J. S. 2009. Characterization of Bacillus polyfermenticus KJS-2 as a probiotic. J. Microbiol. Biotechnol. 19, 1013-1018. https://doi.org/10.4014/jmb.0903.113
  15. Kim, K. M., Kim, T. H., Park, Y. J., Kim, I. H. and Kang, J. S. 2009. Evaluation of the genotoxicity of decursin and decursinol angelate produced by Angelica gigas Nakai. Mol. Cell. Toxicol. 5, 83-87.
  16. Kim, K. M., Lee, Y. J., Hong, Y. G. and Kang, J. S. 2009. Oral acute and subacute toxicity studies of decursin and decursinol angelate of Angelica gigas Nakai. Mol. Cell. Toxicol. 5, 153-159.
  17. Kim, K. M., Seo, J. L. and Kang, J. S. 2014. Decursin and decursinol angelate affect spermatogenesis in the adult rat at oral administration. Mol. Cell. Toxicol. 10, 83-89. https://doi.org/10.1007/s13273-014-0010-2
  18. Kim, M. K., Kwon, B. M., Bae, K. H., Choi, D. H. and Lee, H. J. 1999. Screening of Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors from natural sources. Kor. J. Pharmacogn. 30, 384-396.
  19. Kim, S. H., Ahn, B. C., Joung, H. J. and Park, M. J. 2012. Lipid profiles and prevalence of dyslipidemia in Korean adolescents. Endocrinol. Metab. 27, 208-216. https://doi.org/10.3803/EnM.2012.27.3.208
  20. Kim, W. T. 2012. Effect of Angelica gigas Nakai extract on hepatic damage in rats. Master. dissertation, Kyung-sung university, Busan, Korea.
  21. Korea Institute for Health & Social Affairs. Korean Statistical Information Service. The statistics of DT_33109_A206, http://kosis.kr/statHtml/statHtml.do?orgId=331&tblId=DT_33109_A206&conn_path=I3
  22. Ok, S., Lee, J. H., Kim, I. H. and Kang, J. S. 2011. Glucose transporters and AMP-activated protein kinase modulation effects of decursin and decursinol angelate on diabetic rats. Yakhak Hoeji 55, 301-308.
  23. Ooi, L. G. and Liong, M. T. 2010. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int. J. Mol. Sci. 11, 2499-2522. https://doi.org/10.3390/ijms11062499
  24. Park, H. Y. 2000. Hyperlipidemia. Kor. J. Med. 59, 596-599.
  25. Park, I. S., Ahn, S. H. and Kim, J. T. 1997. Accumulation of lipid including cholesterol in murine hepatocytes with hyperlipidemia induced by Triton WR-1339. Dongguk J. The Institute of Oriental Medicine 6, 107-115.
  26. Song, H. G. and Lee, H. 2011. The Effects of persicae semen herbal-acupuncture at GB34 (Yangneungcheon) on a rat model of hyperlipidemia. J. Kor. Med. 32, 151-163.
  27. Tsai, C. C., Lin, P. P., Hsieh, Y. M., Zhang, Z. Y., Wu, H. C. and Huang, C. C. 2014. Cholesterol-lowering potentials of lactic acid bacteria based on bile-Salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo. Scientific World Journal 2014, 690752.
  28. Virginia, A., Rachmawati, H., Riani, C. and Retnoningrum, D. S. 2016. Study of HMG-CoA reductase inhibition activity of the hydrolyzed product of snakehead fish (Channa striata) skin collagen with 50 kDa collagenase from Bacillus licheniformis F11.4. Sci. Pharm. 84, 81-88. https://doi.org/10.3797/scipharm.ISP.2015.01
  29. Xie, L., Li, J., Xie, L. and Bourne, P. E. 2009. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput. Biol. 5, e1000387. https://doi.org/10.1371/journal.pcbi.1000387
  30. Yu, B. Y., Kim, Y. S. and Yoo, B. W. 2012. Management of dyslipidemia in primary care. Kor. J. Fam. Pract. 2, 98-103.